Arcus Biosciences, Inc. (RCUS)
25.14
-0.40
(-1.55%)
USD |
NYSE |
Sep 18, 16:00
25.14
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Market Cap : 3.193B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 3.244B |
| September 16, 2026 | 3.131B |
| September 15, 2026 | 3.089B |
| September 14, 2026 | 3.057B |
| September 11, 2026 | 3.123B |
| September 10, 2026 | 3.321B |
| September 09, 2026 | 3.618B |
| September 08, 2026 | 3.691B |
| September 04, 2026 | 3.767B |
| September 03, 2026 | 3.827B |
| September 02, 2026 | 3.791B |
| September 01, 2026 | 3.773B |
| August 31, 2026 | 3.719B |
| August 28, 2026 | 3.710B |
| August 27, 2026 | 3.885B |
| August 26, 2026 | 3.907B |
| August 25, 2026 | 4.009B |
| August 24, 2026 | 3.825B |
| August 21, 2026 | 3.853B |
| August 20, 2026 | 3.749B |
| August 19, 2026 | 3.854B |
| August 18, 2026 | 3.748B |
| August 17, 2026 | 3.754B |
| August 14, 2026 | 3.744B |
| August 13, 2026 | 3.665B |
| Date | Value |
|---|---|
| August 12, 2026 | 3.678B |
| August 11, 2026 | 3.650B |
| August 10, 2026 | 3.647B |
| August 07, 2026 | 3.635B |
| August 06, 2026 | 3.598B |
| August 05, 2026 | 3.518B |
| August 04, 2026 | 3.658B |
| August 03, 2026 | 3.508B |
| July 31, 2026 | 3.538B |
| July 30, 2026 | 3.545B |
| July 29, 2026 | 3.319B |
| July 28, 2026 | 3.395B |
| July 27, 2026 | 3.494B |
| July 24, 2026 | 3.567B |
| July 23, 2026 | 3.731B |
| July 22, 2026 | 3.761B |
| July 21, 2026 | 3.700B |
| July 20, 2026 | 3.535B |
| July 17, 2026 | 3.435B |
| July 16, 2026 | 3.343B |
| July 15, 2026 | 3.517B |
| July 14, 2026 | 3.555B |
| July 13, 2026 | 3.523B |
| July 10, 2026 | 3.629B |
| July 09, 2026 | 3.760B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 12.85B |
| AVITA Medical, Inc. | 339.89M |
| Iovance Biotherapeutics, Inc. | 4.638B |
| Editas Medicine, Inc. | 416.07M |
| Recursion Pharmaceuticals, Inc. | 2.046B |
Market Cap Related Metrics
| PS Ratio | 25.60 |
| PEG Ratio | -0.2779 |
| Price to Book Value | 6.882 |
| Price | 25.14 |
| Earnings Yield | -15.53% |
| PEGY Ratio | -0.2779 |